Terms: = Germ cell tumor AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG
133 results:
1. Characterisation of the tumour microenvironment in primary and recurrent glioblastomas.
Knudsen AM; Ewald JD; Pedersen V; Haupt-Jorgensen M; Hansen EVR; Kristensen BW
Neuropathol Appl Neurobiol; 2024 Oct; 50(5):e13012. PubMed ID: 39449228
[TBL] [Abstract] [Full Text] [Related]
2. Single-cell transcriptomic analysis reveals that the APP-cd74 axis promotes immunosuppression and progression of testicular tumors.
Chen G; Wang W; Wei X; Chen Y; Peng L; Qu R; Luo Y; He S; Liu Y; Du J; Lu R; Li S; Fan C; Chen S; Dai Y; Yang L
J Pathol; 2024 Nov; 264(3):250-269. PubMed ID: 39161125
[TBL] [Abstract] [Full Text] [Related]
3. Therapeutic modulation of APP-cd74 axis can activate phagocytosis of TAMs in GBM.
Ma C; Chen J; Ji J; Zheng Y; Liu Y; Wang J; Chen T; Chen H; Chen Z; Zhou Q; Hou C; Ke Y
Biochim Biophys Acta Mol Basis Dis; 2024 Dec; 1870(8):167449. PubMed ID: 39111632
[TBL] [Abstract] [Full Text] [Related]
4. The cytoglobin-dependent transcriptome in melanoma indicates a protective function associated with oxidative stress, inflammation and cancer-associated pathways.
De Backer J; Hoogewijs D
Sci Rep; 2024 Aug; 14(1):18175. PubMed ID: 39107431
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic and therapeutic insights into MIF, DDT, and cd74 in melanoma.
Valdez CN; Sánchez-Zuno GA; Osmani L; Ibrahim W; Galan A; Bacchiocchi A; Halaban R; Kulkarni RP; Kang I; Bucala R; Tran T
Oncotarget; 2024 Jul; 15():507-520. PubMed ID: 39028303
[TBL] [Abstract] [Full Text] [Related]
6. Identification of T2W hypointense ring as a novel noninvasive indicator for glioma grade and IDH genotype.
Lu Y; Du N; Fang X; Shu W; Liu W; Xu X; Ye Y; Xiao L; Mao R; Li K; Lin G; Li S
Cancer Imaging; 2024 Jun; 24(1):80. PubMed ID: 38943156
[TBL] [Abstract] [Full Text] [Related]
7. The role of macrophage migration inhibitory factor family and cd74 in the pathogenesis of melanoma.
Tanese K; Ogata D
Exp Dermatol; 2024 Jun; 33(6):e15122. PubMed ID: 38884501
[TBL] [Abstract] [Full Text] [Related]
8. Multiomics sequencing and immune microenvironment characteristics define three subtypes of small cell neuroendocrine carcinoma of the cervix.
Pan B; Yan S; Yuan L; Xiang H; Ju M; Xu S; Jia W; Li J; Zhao Q; Zheng M
J Pathol; 2024 Jul; 263(3):372-385. PubMed ID: 38721894
[TBL] [Abstract] [Full Text] [Related]
9. A multicenter proof-of-concept study on deep learning-based intraoperative discrimination of primary central nervous system lymphoma.
Zhang X; Zhao Z; Wang R; Chen H; Zheng X; Liu L; Lan L; Li P; Wu S; Cao Q; Luo R; Hu W; Lyu S; Zhang Z; Xie D; Ye Y; Wang Y; Cai M
Nat Commun; 2024 May; 15(1):3768. PubMed ID: 38704409
[TBL] [Abstract] [Full Text] [Related]
10. Preoperative anemia: impact on short- and long-term outcomes following curative-intent resection of gastroenteropancreatic neuroendocrine tumors.
Xiang JX; Nan YL; He J; Lopez-Aguiar AG; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Maithel SK; Lv Y; Zhang XF; Pawlik TM
J Gastrointest Surg; 2024 Jun; 28(6):852-859. PubMed ID: 38538480
[TBL] [Abstract] [Full Text] [Related]
11. A subregion-based RadioFusionOmics model discriminates between grade 4 astrocytoma and glioblastoma on multisequence MRI.
Wei R; Lu S; Lai S; Liang F; Zhang W; Jiang X; Zhen X; Yang R
J Cancer Res Clin Oncol; 2024 Feb; 150(2):73. PubMed ID: 38305926
[TBL] [Abstract] [Full Text] [Related]
12. Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanoma.
Wang Q; Liu W; Zhou H; Lai W; Hu C; Dai Y; Li G; Zhang R; Zhao Y
Neoplasia; 2024 Feb; 48():100966. PubMed ID: 38237304
[TBL] [Abstract] [Full Text] [Related]
13. Engineering human pluripotent stem cell lines to evade xenogeneic transplantation barriers.
Pizzato HA; Alonso-Guallart P; Woods J; Connelly JP; Fehniger TA; Atkinson JP; Pruett-Miller SM; Monsma FJ; Bhattacharya D
Stem Cell Reports; 2024 Feb; 19(2):299-313. PubMed ID: 38215755
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of HASTE versus EPI-Based DWI for Retinoblastoma and Correlation with Prognostic Histopathologic Parameters.
Sharma M; Gupta A; Jana M; Kashyap S; Bakhshi S; Sharma S
AJNR Am J Neuroradiol; 2024 Feb; 45(2):198-204. PubMed ID: 38176729
[TBL] [Abstract] [Full Text] [Related]
15. Investigating the causal impact of gut microbiota on glioblastoma: a bidirectional Mendelian randomization study.
Zeng C; Zhang C; He C; Song H
BMC Genomics; 2023 Dec; 24(1):784. PubMed ID: 38110895
[TBL] [Abstract] [Full Text] [Related]
16. Post-operative interventional radiotherapy (brachytherapy) in advanced ocular surface and eyelid tumors as an alternative to surgical retreatment.
Cuffaro G; Fionda B; Piccinni F; Pagliara MM; Sammarco MG; Blasi MA; Molinario C; Castri F; Tagliaferri L; Massi D; Savino G
Eur J Ophthalmol; 2024 Jul; 34(4):1266-1276. PubMed ID: 38105586
[TBL] [Abstract] [Full Text] [Related]
17. Machine Learning Methods Based on CT Features Differentiate G1/G2 From G3 Pancreatic Neuroendocrine tumors.
Chen HY; Pan Y; Chen JY; Chen J; Liu LL; Yang YB; Li K; Ma Q; Shi L; Yu RS; Shao GL
Acad Radiol; 2024 May; 31(5):1898-1905. PubMed ID: 38052672
[TBL] [Abstract] [Full Text] [Related]
18. Prognosis of CDKN2A germline mutation in patients with familial melanoma: a systematic review and meta-analysis.
Taibo A; Paradela S; Suanzes-Hernández J; Balboa-Barreiro V; Amado-Bouza J; Fonseca E
Melanoma Res; 2024 Feb; 34(1):9-15. PubMed ID: 37924530
[TBL] [Abstract] [Full Text] [Related]
19. New Cancer Diagnoses Before and During the COVID-19 Pandemic.
Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Pitz M; Singh H; Thiessen M; Lambert P
JAMA Netw Open; 2023 Sep; 6(9):e2332363. PubMed ID: 37669049
[TBL] [Abstract] [Full Text] [Related]
20. Automated, fast, robust brain extraction on contrast-enhanced T1-weighted MRI in presence of brain tumors: an optimized model based on multi-center datasets.
Teng Y; Chen C; Shu X; Zhao F; Zhang L; Xu J
Eur Radiol; 2024 Feb; 34(2):1190-1199. PubMed ID: 37615767
[TBL] [Abstract] [Full Text] [Related]
[Next]